Giancarlo Pruneri

University of Milan, post-graduate school of pathology, National Cancer Institute Milan, Editor-in-Chief Tumori Journal

[Sage Sociology @SageSociology]

Fantastic to see What Do We Know & What Should We Do About #FakeNews? by @NickAnstead featured on @LSEImpactBlog's 2021 in review!

'A solid touchpoint for people looking to understand one of the most pressing issues of our time.'

Get your copy here: https://t.co/1cmHJAoe3z

[Tumori Journal @TumoriJ]

Over 1200 papers submitted to @TumoriJ in 2021‼️

🙏Thanking to our #sectioneditors, #reviewers and #authors, TJ team wishes happy and prosperous #NewYear2022 🍾🥂

https://t.co/6grsuMjIrk

[National Cancer Institute @theNCI]

As 2021 comes to a close, we are featuring our top social media posts as chosen by you, our followers. Follow this week-long series and be sure to check out any of the posts you may have missed this year! https://t.co/d8rdyOPnII #BestOf2021 #NCIHighlights2021 #NothingWillStopUs

[Prof. Feynman @ProfFeynman]

Teach your children early what you learned late.

[Tumori Journal @TumoriJ]

Neoadjuvant chemotherapy💊 followed by interval debulking surgery for unresectable stage IVB Serous #endometrialcancer👇

#TJArchive🆓
https://t.co/ELd4wQxYVZ

@PayamKashiMD @kahramanogluiMD @VCCLibrary @Mikhail_MIGS #GynecologicOncology #GYNOnc

[ESOncology @ESOncology]

Reminder to all pathologists and oncologists interested in digital transformation of pathology laboratories: the ESO-ESP Digital Pathology Seminar will be held on 11/12 DECEMBER 2021. Registration is FREE but mandatory 👉https://t.co/L6Tf352kd2. @ESP_Pathology #ESOexperience

[Tumori Journal @TumoriJ]

🎙️“Based on a true story" #podcast: a #journey into the world of young patients w/ cancer🚶‍♀️🚶👩‍🦽🚶‍♂️ by A Ferrari et al

#YouthProject @IstTumori tends to clinical and psychological needs of #adolescent #AYA pts

▶️https://t.co/loyJHidzK6

@Radio24_news @Signoroni @carloaclerici

[Giampaolo Bianchini @BianchiniGP]

#TNBC revolution: not so negative any more‼️
Expanding targets: g/sBRCA1/2mut, gPALB2mut,TROP2, PD-L1+, HER2low, HER3, ERBB2mut, AKT1mut, NTRK, TMB-high, MSI-H
Expanding options: pembro, atezo (EU), sacituzumab, olaparib, talazoparib
Read more https://t.co/pxmnyjVNvj
#bcsm

[Tumori Journal @TumoriJ]

✍️Most cited #TumoriJournal articles

Updating novel #inflammasome pathway-targeting agents for #immunotherapy and target therapy ➕ future research directions of inflammasome-based #targettherapy 🎯💊

🔓https://t.co/K2StZ051Wi
@inflammasomelab @WuLabHarvard @carmonation

[Stefano Magno @stemagno74]

"#Fasting mimicking diet reshapes anticancer #immunity by inducing contraction of peripheral blood immunosuppressive myeloid/T-reg, enhanced intratumor Th1/cytotoxic responses & enrichment of signatures associated with better clinical outcomes in #cancer pts" @PruneriG @OncoAlert

[EORTC @EORTC]

Last chance to register!

Don't forget to join our free webinar on prostate cancer open to everyone on Wednesday!

📅November 24, 2021
⏰1-2pm CET

More info: https://t.co/3wndBdYoBc

#Movember #CancerResearch @OncoAlert

[Tumori Journal @TumoriJ]

✨✨🧙 Illusionist techniques as a complement to psychological support for children with cancer

Preliminary descriptive experience by @carloaclerici et al @IstTumori
🔓
https://t.co/1sdWC2nZXq

#WorldChildrensDay #PediatricOncology #ChildhoodCancer #PsyOnc @WorldSIOP

[Giampaolo Bianchini @BianchiniGP]

📢Proud to present our manuscript 'Treatment landscape of triple-negative breast cancer — expanded options, evolving needs' which has just been published with @SpringerNature in @NatRevClinOncol
If you are intrested read here: https://t.co/pxmnyjVNvj
#bcsm #TNBC
@OncoAlert

[European Society of Pathology (ESP) @ESP_Pathology]

#PathTwitter Happy #InternationalPathologyDay 2⃣0⃣2⃣1⃣! 🎀🎈🎈🔬🔬🔬
Many ESP affiliated National Societies and other Pathology institutions organise events and press releases to advertise the role of Pathology in modern Medicine!
#pathology

[Tumori Journal @TumoriJ]

Predatory publishers adopt tactics of bootlegged articles & rebranding to feed fake open access journals and cheat researchers ⚠️

On @Nature, @KyleSile @philvlam @csugimoto @lariviev dig deep into the Hydra phenomenon, suggesting how to stop it 👇

https://t.co/MmvYOo3EI2

[Tumori Journal @TumoriJ]

📌11-12 Dec | @EloyCatarina and @PruneriG, #TumoriJournal EiC, will be Co-Chairs of the @ESOncology & @ESP_Pathology Digital Pathology Seminar focused on digital transformation of #pathology laboratorie and consequent benefits🎯

Free of charge, program👇
https://t.co/ObYMqFnITs

[Tumori Journal @TumoriJ]

🔔 #OpenAccessWeek

👩‍💻 Discover the services and guarantees of a legitimate scientific publisher 📚
Avoid the risk of a predator🐊

#OAWeek2021
#openaccessweek2021

[Tumori Journal @TumoriJ]

📍24 Oct 9.45 #AIOMCongress 🇮🇹 | Symposium #GenomicTests ➡️validation, scientific evidence and selection criteria #bcsm

Here @PruneriG and CA Tondini: The use of genomic tests in patients w/ #breastcancer in Lombardy: a successful healthcare model
👇
https://t.co/zKSgh9MPrR

[The Lancet Oncology @TheLancetOncol]

Online first: Effect of #COVID19 #pandemic #lockdowns on planned #cancer #surgery for 15 tumour types in 61 countries @DrJamesGlasbey @aneelbhangu @COVIDSurg
https://t.co/K4vPxFXqYh